Ariad Pharm Inc (ARIA)
23.99 +0.04 (+0.17%) 02/15/17 [NASDAQ]
N/A x N/A N/A x N/A
Realtime by (Cboe BZX)
N/A x N/A N/A x N/A
Realtime - - (-) -
for Wed, Feb 15th, 2017
Results
download Want to compare other data? Select Fields| Symbol | ARIA | IONS | CRNX | ||
| Company | Ariad Pharm Inc | Ionis Pharmaceuticals | Crinetics Pharmaceuticals Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 23.95 | 33.10 | 34.46 | ||
| High | 23.99 | 34.13 | 35.54 | ||
| Low | 23.94 | 32.84 | 34.46 | ||
| Last | 23.99 | 33.41 | 35.40 | ||
| Change | +0.04 | +0.38 | +1.14 | ||
| % Change | +0.17% | +1.15% | +3.33% | ||
| Volume | 7,220,900 | 2,084,400 | 652,700 | ||
| 20-Day Average Volume | 8,662,590 | 1,843,135 | 994,075 | ||
| Previous Close | 23.95 | 33.03 | 34.26 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 23.79 | 32.36 | 34.68 | ||
| 20-Day Raw Stochastic | 100.00% | 66.67% | 61.01% | ||
| 20-Day Relative Strength | 83.87% | 51.40% | 43.61% | ||
| Weighted Alpha | +164.00 | -23.87 | -21.36 | ||
| Today's Opinion | N/A | 56% Sell | 88% Sell | ||
| Previous Opinion | N/A | 64% Sell | 100% Sell | ||
| Last Month's Opinion | N/A | 100% Sell | 88% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.50% since 02/08/17 | -1.01% since 03/05/25 | +4.27% since 03/05/25 | ||
| Low | 23.85 on 02/10/17 | 31.46 on 03/11/25 | 32.63 on 03/07/25 | ||
| High | 23.99 on 02/15/17 | 35.00 on 03/06/25 | 35.54 on 03/12/25 | ||
| 1-Month | |||||
| %Chg | +1.27% since 01/13/17 | +8.33% since 02/12/25 | +0.54% since 02/12/25 | ||
| Low | 23.63 on 01/27/17 | 30.23 on 02/13/25 | 31.84 on 02/25/25 | ||
| High | 23.99 on 02/15/17 | 35.00 on 03/06/25 | 37.67 on 02/24/25 | ||
| 3-Month | |||||
| %Chg | +81.74% since 11/15/16 | -9.73% since 12/12/24 | -36.35% since 12/12/24 | ||
| Low | 11.69 on 12/22/16 | 30.23 on 02/13/25 | 31.84 on 02/25/25 | ||
| High | 23.99 on 02/15/17 | 38.90 on 12/16/24 | 56.53 on 12/13/24 | ||
| 6-Month | |||||
| %Chg | +125.05% since 08/15/16 | -18.55% since 09/12/24 | -30.90% since 09/12/24 | ||
| Low | 8.63 on 11/03/16 | 30.23 on 02/13/25 | 31.84 on 02/25/25 | ||
| High | 23.99 on 02/15/17 | 43.50 on 09/19/24 | 62.53 on 11/14/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 4,663,416 | 5,250,614 | 3,187,859 | ||
| Shares Outstanding, K | 194,390 | 158,965 | 93,049 | ||
| Annual Sales | 118,800,000 | 705,140,000 | 1,040,000 | ||
| Annual Net Income | -231,160,000 | -453,900,000 | -298,410,000 | ||
| Last Quarter Sales | 46,020,000 | 226,580,000 | 0 | ||
| Last Quarter Net Income | -27,830,000 | -104,350,000 | -76,830,000 | ||
| 60-Month Beta | 2.16 | 0.28 | 0.58 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.12 on 11/07/16 | -0.66 on 02/19/25 | -0.88 on 02/27/25 | ||
| Latest Earnings Date | 02/28/17 | 05/06/25 | 02/27/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||